HomeStock ScreenerEverest Organics

Everest Organics Share Price | Everest Organics Stock Screener

EVERESTO Pharmaceuticals
Share Price BSE
₹260.00
▲ 9.15 (3.65%)
2026-05-21 00:00:00
As of May 21, 2026, the Everest Organics share price (BSE: EVERESTO) is ₹260.00, up 3.65% from the previous close, with shares trading between ₹251.00 and ₹267.00, and a 52-week range of ₹203.45–₹522.50. Check EVERESTO price range for the annual price range and momentum. Use the Everest Organics stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Everest Organics Market Cap ₹250.54 Cr.
EVERESTO P/E Ratio (TTM) 43.25
Everest Organics P/B Ratio 3.48
EPS (TTM) ₹-2.97
Dividend Yield -
Debt to Equity 0.91
EVERESTO 52 Week High ₹522.50
Everest Organics 52 Week Low ₹203.45
Operating Margin 9.00%
Profit Margin 3.16%
EVERESTO Revenue (TTM) ₹190.00
EBITDA ₹18.00
Net Income ₹6.00
Total Assets ₹225.00
Total Equity ₹70.00

Everest Organics Share Price Chart

Screen Everest Organics share price with an interactive chart. Analyse EVERESTO price trends and volatility across different timeframes.

Everest Organics Company Profile - Fundamental Screener

Screen Everest Organics company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for EVERESTO shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE334C01029

Everest Organics Balance Sheet Screener

Screen EVERESTO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Assets
Total Assets 225 227 202 178 135 120 107 94 86 76
Current Assets 148 150 133 118 89 79 67 58 49 47
Fixed Assets 50 52 55 49 44 39 39 34 33 27
Liabilities
Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 15 21 18 19 11 12 10 8 7 14
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 70 46 46 47 47 34 26 19 16 6
Share Capital 10 8 8 8 8 8 8 8 8 3
Reserves & Surplus 59 38 38 39 39 26 18 11 8 3

Everest Organics Income Statement Screener - Profit & Revenue Analysis

Screen Everest Organics income statement and profit fundamentals. Analyze EVERESTO quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Everest Organics share price evaluation.
Item None-None 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March
Revenue 190 160 198 190 202 183 169 156 113 108 100 107
Expenses 172 152 186 182 194 159 148 138 105 101 94 98
EBITDA 18 8 12 8 9 24 21 18 8 7 6 8
Operating Profit % 9.00% 5.00% 6.00% 1.00% 3.00% 13.00% 11.00% 11.00% 6.00% 6.00% 6.00% 7.00%
Depreciation 6 6 6 5 4 3 3 3 3 2 3 3
Interest 5 5 6 3 3 3 3 3 3 3 3 3
Profit Before Tax 7 -3 1 0 2 17 14 12 2 2 0 2
Tax 2 -2 1 0 1 4 3 5 1 0 0 0
Net Profit 6 -1 0 0 1 14 11 8 2 1 0 2
EPS 6.00 -2.97 0.17 -0.23 1.43 17.14 13.62 9.39 2.14 1.69 0.54 1.78

Everest Organics Cash Flow Screener - Liquidity Fundamentals

Screen EVERESTO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March
Operating Activities -5 16 18 14 14 10 9 5 10 7
Investing Activities -5 -13 -16 -17 -12 -6 -5 -4 -8 -7
Financing Activities 16 -3 -3 2 -2 -3 -3 -1 -2 0
Net Cash Flow 6 0 0 -1 0 0 1 0 0 0

Everest Organics Shareholding Pattern Screener

See Everest Organics shareholding pattern with promoter, FII, and DII holdings. Check Everest Organics promoter holding and ownership changes for EVERESTO on TickJournal.
Item 2026-Mar 2025-Jan 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun
Promoter Holding 59.58% 61.09% 61.09% 60.99% 59.64% 59.61% 74.15% 74.15%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.06% 0.06%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 26.91% 32.22% 23.87% 25.35% 25.98% 26.10% 20.00% 20.05%
Other Holding 13.48% 6.67% 15.02% 13.64% 14.35% 14.26% 5.79% 5.75%
Shareholder Count 7,880 8,795 8,756 8,281 8,079 7,804 10,023 9,792

Everest Organics Share Dividend Screener - Share Yield Analysis

Check Everest Organics dividend history with payout and yield data. View Everest Organics dividend details including ex-dates and amounts for EVERESTO stock.
Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.00 0.00%
2024-March ₹0.00 0.00%
2023-March ₹0.00 0.00%
2022-March ₹0.00 0.00%
2021-March ₹1.50 0.86%
2020-March ₹1.00 0.43%
2019-March ₹1.00 1.05%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Everest Organics Stock Index Membership

See which indices include Everest Organics stock. Check EVERESTO index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Everest Organics is not part of any tracked indices.
Only major market indices are tracked in our system.

Everest Organics Market Events Screener - Corporate Actions

Get Everest Organics corporate actions including splits, bonuses, and buybacks. Check Everest Organics stock events that may affect EVERESTO share price.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA 25.93%
Dividend ₹ 1.00 /share -16.77%
Dividend ₹ 0.50 /share -6.05%
Annual General Meeting NA -3.38%
2026-02-14 2026-02-14 Quarterly Result Announcement NA -0.90%
2025-11-12 2025-11-12 Quarterly Result Announcement NA 0.21%
2025-08-05 2025-08-05 Quarterly Result Announcement NA -5.94%
2025-05-27 2025-05-27 Quarterly Result Announcement NA 7.42%
2025-02-11 2025-02-11 Quarterly Result Announcement NA 0.76%
2025-01-08 2025-01-08 Extraordinary General Meeting NA 36.35%
2024-11-13 2024-11-13 Quarterly Result Announcement NA -6.74%
2021-02-17 2021-02-18 Dividend ₹ 0.50 /share -9.19%

Everest Organics Competitors Screener - Peer Comparison

Screen EVERESTO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 450,643 40.81 54,729 9.71% 10,980 64.89
Divis Laboratories 179,470 74.13 9,712 18.67% 2,191 64.06
Torrent Pharmaceuticals 149,109 65.68 11,539 6.99% 1,911 58.52
Cipla 115,682 30.09 27,712 -2.46% 3,783 69.78
Dr Reddys Laboratories 111,567 26.16 33,593 -0.44% 3,998 59.87
Lupin 104,032 19.28 27,488 19.98% 5,345 46.11
Mankind Pharma 103,325 56.36 12,744 20.90% 2,007 73.37
Zydus Life Science 101,801 19.85 23,511 18.55% 4,615 69.47
Aurobindo Pharma 87,806 25.16 32,346 9.43% 3,484 73.83
Laurus Labs 71,455 79.78 6,813 21.03% 884 80.26

Everest Organics Company Announcements - News Screener

Screen EVERESTO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-04-10 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-04-07 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-03-23 Closure of Trading Window -
2026-03-06 Disclosure Of Reasons For Delay In Submission Of Financial Results For The Quarter Ended December 31 2025 Under Regulation 33 Of SEBI (LODR) Regulations 2015 -
2026-02-16 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-02-15 Unaudited Financial Results For The Quarter Ended And Nine Months Ended December 31 2025. -
2026-02-15 Board Meeting Outcome for Outcome Of Board Meeting Dated February 14 2026 - Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025 -
2026-02-15 Board Meeting Outcome for Outcome Of Board Meeting Dated February 14 2026 - Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025 -
2026-02-14 Newspaper Publication -
2026-02-12 Board Meeting Intimation for Intimation Regarding Postponement And Rescheduling Of Board Meeting. -
2026-02-03 Board Meeting Intimation for Un-Audited Financial Results Along With The Limited Review Report Of The Company For The Quarter Ended December 31 2025. -
2026-01-22 Report On Re-Lodgement Of Transfer Request Of Physical Shares -
2026-01-17 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-12-23 Closure of Trading Window -
2025-12-17 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report -
2025-12-17 Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot -
2025-12-17 Intimation Of Newspaper Publication With Respect To Special Window For Re-Lodgement Of Physical Share Transfer Requests -
2025-12-12 Monthly Report On Special Window For Re-Lodgement Of Transfer Request Of Physical Shares For The Month Of December 2025. -
2025-11-17 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2025-11-15 Shareholder Meeting / Postal Ballot-Notice of Postal Ballot -